Jade Road Investments Limited Strategic partnership with MBM Limited

RNS Number : 8150A

Jade Road Investments Limited

16 August 2024

 

Jade Road Investments Limited

16 August 2024

JADE ROAD INVESTMENTS LIMITED

("Jade Road Investments", "JADE" or the "Company)

Strategic partnership with MBM Limited

Jade Road Investments Limited (AIM: JADE) is pleased to announce that it has entered into a strategic partnership with MBM Limited (MBM), pursuant to which MBM will both make potential investment introductions to Jade as well as providing it with new capital in the form of a convertible loan.

MBM provides comprehensive consultancy services designed to support companies in various aspects of growth and investment, including fundraising, marketing, deal sourcing, board strengthening and investor communication. With a collective experience of over 70 years, the expert team at MBM works closely with businesses, often taking equity stakes to align its performance with the goals of company owners and shareholders. This hands-on approach ensures that MBM not only delivers strategic guidance but also has a vested interest in the success and sustainability of the businesses it supports, fostering a collaborative environment that enhances overall performance and drives long-term value.

Jade will constitute up to £300,000 in principal value of convertible loan notes (CLN). The CLN is non-interest bearing, has a maturity of 10 months and is convertible at either MBM or the Company's option into JADE shares at a price which is 30% below the lowest closing bid price over the 30 business days prior to the date on which either party notifies the other it wishes to convert.  Subject to agreement with MBM, Jade will issue tranches of the CLN to MBM, the first of which has been agreed in the sum of £80,000 and which will be paid for by MBM within 30 days of MBM being issued the Commission Shares referred to below.

MBM has agreed to take its commission for making successful investment introductions to Jade and investing in the CLN in the form of Jade shares.  Accordingly, an initial 25,000,000 Jade shares have today been issued to MBM (Commission Shares)

Further announcements will be made in regard to CLN drawdowns will be made in due course.

The partnership is in its early stages, but initial discussions with several founders and management of new investment opportunities have already begun, each of whom are showing significant interest in partnering with the Company and accepting Jade shares in exchange for stakes in their businesses.

Further announcements will be released to update on further tranches of the CLN being issued to MBM as well as updates on target investment opportunities.

The board of Jade Road is excited about the prospects this partnership presents and looks forward to providing further updates in the near future.

Application will be made to AIM for Admission, which is expected to become effective and dealings in the initial tranche of 25,000,000 shares to commence at, 8.00 a.m. on or around 19 August 2024.

Following Admission, the total voting rights in the Company will therefore be 380,545,330 and Shareholders will be able to use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

 

 

For further information, please contact:

 

Jade Road Investments Limited

 

[phone]

John Croft

 

Zeus Capital Limited - Nominated Adviser

 

[phone]

James Joyce

 

Hybridan LLP - Nominated Broker

 

[phone]

Claire Louise Noyce

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

AGRGPURURUPCGCQ